Fingerprint
Dive into the research topics of 'Vorinostat and sorafenib synergistically kill tumor cells via FLIP suppression and CD95 activation'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Vorinostat and sorafenib synergistically kill tumor cells via FLIP suppression and CD95 activation
Guo Zhang, Margaret A. Park, Clint Mitchell, Hossein Hamed, Mohamed Rahmani, Aditi Pandya Martin, David T. Curiel, Adly Yacoub, Martin Graf, Ray Lee, John D. Roberts, Paul B. Fisher, Steven Grant, Paul Dent
- Bursky Center for Human Immunology & Immunotherapy Programs (CHiiPs)
- Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
- Institute of Clinical and Translational Sciences (ICTS)
- Siteman Cancer Center
- Department of Radiation Oncology
- Center of Regenerative Medicine
- DBBS - Developmental, Regenerative and Stem Cell Biology
- DBBS - Immunology
- DBBS - Molecular Microbiology and Microbial Pathogenesis
- DBBS - Molecular Genetics and Genomics
- Brain Tumor Center
Research output: Contribution to journal › Article › peer-review
102
Scopus
citations